Literature DB >> 25121565

Balancing competing risks: perinatal exposure to macrolides increases the risk of infantile hypertrophic pyloric stenosis.

Margaret A Honein1, Janet D Cragan1.   

Abstract

Entities:  

Keywords:  EPIDEMIOLOGY; NEONATOLOGY

Mesh：

Substances：

Year:  2014        PMID： 25121565      PMCID： PMC4559230          DOI： 10.1136/ebmed-2014-110015

Source DB:  PubMed          Journal:  Evid Based Med        ISSN： 1356-5524


× No keyword cloud information.
  4 in total

1.  Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines.

Authors:  Tejpratap Tiwari; Trudy V Murphy; John Moran
Journal:  MMWR Recomm Rep       Date:  2005-12-09

Review 2.  Infantile hypertrophic pyloric stenosis: epidemiology, genetics, and clinical update.

Authors:  Judith D Ranells; Jane D Carver; Russell S Kirby
Journal:  Adv Pediatr       Date:  2011

3.  Safety of macrolides during pregnancy.

Authors:  Kueiyu Joshua Lin; Allen A Mitchell; Wai-Ping Yau; Carol Louik; Sonia Hernández-Díaz
Journal:  Am J Obstet Gynecol       Date:  2012-12-16       Impact factor: 8.661

4.  Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis.

Authors:  William O Cooper; Marie R Griffin; Patrick Arbogast; Gerald B Hickson; Shiva Gautam; Wayne A Ray
Journal:  Arch Pediatr Adolesc Med       Date:  2002-07
  4 in total
  1 in total

Review 1.  Association between exposure to macrolides and the development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis.

Authors:  Mohammed Abdellatif; Sherief Ghozy; Mohamed Gomaa Kamel; Sameh Samir Elawady; Mohamed Mohy Eldeen Ghorab; Andrew Wassef Attia; Truong Thi Le Huyen; Diep Trong Vien Duy; Kenji Hirayama; Nguyen Tien Huy
Journal:  Eur J Pediatr       Date:  2018-11-23       Impact factor: 3.183
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.